Literature DB >> 3670521

Hypoxanthine transport through the blood-brain barrier.

R Spector1.   

Abstract

The unidirectional influx of hypoxanthine across cerebral capillaries, the anatomical locus of the blood-brain barrier, was measured with an in situ rat brain perfusion technique employing [3H]hypoxanthine. Hypoxanthine was transported across the blood-brain barrier by a saturable system with a one-half saturation concentration of approximately 0.4 mM. The permeability-surface area product was 3 X 10(-4) sec-1 with a hypoxanthine concentration of 0.02 microM in the perfusate. Adenine (4 mM) and uracil and theophylline (both 10 mM), but not inosine (10 mM) or leucine (1 mM), inhibited hypoxanthine transfer through the blood-brain barrier. Thus, hypoxanthine is transported through the blood-brain barrier by a high-capacity, saturable transport system with a half-saturation concentration about 100 times the plasma hypoxanthine concentration. Although involved in the transport hypoxanthine from blood into brain, this system is not powerful enough to transfer important quantities of hypoxanthine from blood into brain.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3670521     DOI: 10.1007/bf00971517

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  20 in total

1.  Nucleotide metabolism in rat brain.

Authors:  J N Santos; K W Hempstead; L E Kopp; R P Miech
Journal:  J Neurochem       Date:  1968-05       Impact factor: 5.372

2.  Purines: active transport by isolated choroid plexus.

Authors:  R D Berlin
Journal:  Science       Date:  1969-03-14       Impact factor: 47.728

3.  Observations on purine metabolism in rat brain.

Authors:  I Held; W Wells
Journal:  J Neurochem       Date:  1969-04       Impact factor: 5.372

4.  Nucleoside transport in choroid plexus: mechanism and specificity.

Authors:  R Spector
Journal:  Arch Biochem Biophys       Date:  1982-07       Impact factor: 4.013

5.  Active absorption of hypoxanthine by lamb jejunum in vitro.

Authors:  E Scharrer; W Raab; W Tiemeyer; B Amann
Journal:  Pflugers Arch       Date:  1981-07       Impact factor: 3.657

6.  Pantothenic acid transport through the blood-brain barrier.

Authors:  R Spector; C Sivesind; D Kinzenbaw
Journal:  J Neurochem       Date:  1986-09       Impact factor: 5.372

7.  Salvage of circulating hypoxanthine by tissues of the mouse.

Authors:  J D Moyer; J F Henderson
Journal:  Can J Biochem Cell Biol       Date:  1983-11

8.  Kinetic analysis of L-leucine transport across the blood-brain barrier.

Authors:  Q R Smith; Y Takasato; S I Rapoport
Journal:  Brain Res       Date:  1984-10-08       Impact factor: 3.252

9.  Hypoxanthine and xanthine levels determined by high-performance liquid chromatography in plasma, erythrocyte, and urine samples from healthy subjects: the problem of hypoxanthine level evolution as a function of time.

Authors:  R Boulieu; C Bory; P Baltassat; C Gonnet
Journal:  Anal Biochem       Date:  1983-03       Impact factor: 3.365

10.  Uridine transport and metabolism in the central nervous system.

Authors:  R Spector
Journal:  J Neurochem       Date:  1985-11       Impact factor: 5.372

View more
  5 in total

1.  Computational prediction of CNS drug exposure based on a novel in vivo dataset.

Authors:  Christel A S Bergström; Susan A Charman; Joseph A Nicolazzo
Journal:  Pharm Res       Date:  2012-06-29       Impact factor: 4.200

Review 2.  Permeability of the Blood-Brain Barrier: Molecular Mechanism of Transport of Drugs and Physiologically Important Compounds.

Authors:  Clifford W Fong
Journal:  J Membr Biol       Date:  2015-02-13       Impact factor: 1.843

3.  Metabolic fingerprints of fear memory consolidation during sleep.

Authors:  Iyo Koyanagi; Kazuhiro Sonomura; Toshie Naoi; Takaaki Ohnishi; Naoko Kaneko; Kazunobu Sawamoto; Taka-Aki Sato; Masanori Sakaguchi
Journal:  Mol Brain       Date:  2021-02-10       Impact factor: 4.041

4.  Characterization of a novel AICARFT inhibitor which potently elevates ZMP and has anti-tumor activity in murine models.

Authors:  Harold B Brooks; Timothy I Meier; Sandaruwan Geeganage; Kevin R Fales; Kenneth J Thrasher; Susan A Konicek; Charles D Spencer; Stefan Thibodeaux; Robert T Foreman; Yu-Hua Hui; Kenneth D Roth; Yue-Wei Qian; Tao Wang; Shuang Luo; Alicia Torrado; Chong Si; James L Toth; Jefferson R Mc Cowan; Kwame Frimpong; Matthew R Lee; Robert D Dally; Timothy A Shepherd; Timothy B Durham; Yong Wang; Zhipei Wu; Philip W Iversen; F George Njoroge
Journal:  Sci Rep       Date:  2018-10-18       Impact factor: 4.379

5.  Improved Parkinsons disease motor score in a single-arm open-label trial of febuxostat and inosine.

Authors:  Hirohisa Watanabe; Tatsuya Hattori; Akito Kume; Kenichiro Misu; Takashi Ito; Yu Koike; Todd A Johnson; Shigeo Kamitsuji; Naoyuki Kamatani; Gen Sobue
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.